SHLT

SHL Telemedicine Ltd. SHLT

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SHLT AKLI SNCE SHCR BACK ORKA GRCE LIANY RENB IRD
6M -23.22 % 72.48 % -28.13 % 71.26 % 228.84 % 176.18 % 13.85 % -78.33 % -60.56 % 110.27 %
YTD -27.56 % -9.34 % 12.75 % 37.50 % -88.87 % 60.84 % -15.75 % -66.84 % -81.39 % 61.90 %
1Y -49.93 % -63.61 % -1.98 % 50.89 % -88.78 % 60.76 % -8.92 % -64.61 % -73.70 % 88.89 %
3Y -85.96 % -95.60 % -97.20 % -76.97 % -97.70 % 16.89 % 11.96 % -94.24 % -93.00 % 58.14 %
5Y -85.96 % -95.72 % -97.19 % -85.70 % -99.63 % -35.66 % 11.96 % -99.34 % -95.34 % 58.14 %
10Y -85.96 % -95.72 % -97.19 % -85.70 % -99.87 % -97.09 % 11.96 % -99.34 % -97.59 % 58.14 %
From the beginning -85.96 % -95.72 % -97.19 % -85.70 % -99.87 % -100.00 % 11.96 % -99.34 % -97.59 % 58.14 %

Dividend

Oruka Therapeutics, Inc.

LianBio